U.S. Water Utilities Stock News

NYSE:WTTR
NYSE:WTTREnergy Services

Select Water Solutions (WTTR) Stock After Earnings Beat And Recycling Expansion How Does The Valuation Stack Up

Select Water Solutions (WTTR) has been in focus after reporting earnings that exceeded analyst expectations on EPS and EBITDA, even as revenue was slightly lower year on year, drawing fresh attention to the stock’s recent move. See our latest analysis for Select Water Solutions. The stock has already reacted to the earnings beat with a 7.7% move higher, and at a latest share price of $18.91 that momentum is reflected in a 90 day share price return of 34.98% and a 1 year total shareholder...
NYSE:EPAM
NYSE:EPAMIT

How EPAM’s Role in TGS’s AI Seismic Platform on AWS Will Impact EPAM Systems (EPAM) Investors

In early June 2026, TGS, together with EPAM Systems and Amazon Web Services, reported the successful deployment of the TGS Imaging AnyWare seismic imaging platform on AWS, enabling faster, cloud-based, AI-enabled workflows for energy companies. This collaboration highlights EPAM’s role in building OSDU-compliant, cloud-native data and AI infrastructure for complex industrial workloads, potentially broadening its reach in the energy technology market. We’ll now examine how EPAM’s role in...
NYSE:XYZ
NYSE:XYZDiversified Financial

Block (SQ) Stock Valuation After Q1 Beat Raised 2026 Outlook And Goldman Sachs Conviction List Entry

Block (XYZ) is back in focus after Q1 results topped guidance, management lifted its 2026 outlook, and the stock reacted to new financial products plus inclusion on Goldman Sachs’ US Conviction List. See our latest analysis for Block. At a share price of US$69.52, Block has seen a 2.01% 7 day share price return and a 16.27% 90 day share price return. The 1 year total shareholder return of 12.91% sits against headlines around Q1 earnings, new savings products, client case studies like Coffee...
NYSE:MRK
NYSE:MRKPharmaceuticals

The Bull Case For Merck (MRK) Could Change Following First PD-1 Plus HIF-2α Adjuvant Approval

Earlier this week, Merck reported that the FDA approved KEYTRUDA and KEYTRUDA QLEX, each in combination with WELIREG, as adjuvant therapy for adults with clear cell renal cell carcinoma at intermediate-high or high risk of recurrence following surgery, based on disease‑free survival gains in the Phase 3 LITESPARK‑022 trial. This decision introduces the first approved pairing of a PD-1 inhibitor with a HIF-2α inhibitor and extends WELIREG into earlier-stage kidney cancer, broadening Merck’s...
NYSE:RYAN
NYSE:RYANInsurance

Ryan Specialty (RYAN) Faces Weaker Results and Scrutiny Is Management’s Confidence Still Convincing?

In recent days, Ryan Specialty Holdings reported weaker-than-expected fourth-quarter and full-year 2025 results, while also facing securities law investigations and hosting its investor presentation at the Morgan Stanley US Financials Conference 2026 in New York. At the same time, a mix of analyst downgrades, securities law scrutiny, and increased insider share purchases has put a spotlight on how confident management really is in the company’s long-term prospects. We’ll now examine how...
NYSEAM:HYLN
NYSEAM:HYLNElectrical

Hyliion Holdings (HYLN) Stock Valuation After Needham Buy Rating And Karno Commercialization Outlook

Needham’s new Buy rating on Hyliion Holdings (HYLN) has thrown a spotlight on the stock, with the firm highlighting the commercialization prospects for the KARNO power module and a debt-free balance sheet. See our latest analysis for Hyliion Holdings. Hyliion’s recent move follows a sharp re-rating, with the stock posting a 30 day share price return of 106.13% and a year to date share price return of 306.59%. The 1 year total shareholder return stands at 410.34%. If Hyliion’s surge has your...
NYSE:SYF
NYSE:SYFConsumer Finance

Synchrony Financial (SYF) Stock After New Partnerships And Steady Credit Metrics Is The Valuation Gap Still There

Synchrony Financial (SYF) is back in focus after expanding its co brand partnership with Lowe’s and rolling out CareCredit across Pet Resort Hospitality Group locations, while recent monthly credit data points to steady portfolio performance. See our latest analysis for Synchrony Financial. The recent partnerships with Lowe’s and Pet Resort Hospitality Group, combined with steady credit metrics, come as the stock trades at US$73.36 after a 15.02% 90 day share price return, while the 3 year...
NYSE:SPCE
NYSE:SPCEAerospace & Defense

Virgin Galactic (SPCE) Is Down 10.7% After Debt-for-Equity Swap And New Shelf Registration - Has The Bull Case Changed?

Virgin Galactic Holdings has recently redeemed about US$30.5 million of its 9.80% First Lien Notes by issuing roughly 6.73 million shares and filed a US$46.86 million shelf registration for nearly 9,950,000 common shares tied to an employee stock plan, reshaping its capital structure ahead of planned commercial spaceflights. These moves highlight the trade-off between near-term dilution and improved liquidity as Virgin Galactic works toward late-2026 commercial operations and seeks to...
NasdaqGS:NXT
NasdaqGS:NXTElectrical

Is Nextpower (NXT) Just a Geopolitical Trade or a Consistent Earnings Story in Disguise?

In recent days, Nextpower has been swept up in sector-wide swings linked to shifting Iran-related geopolitical risks, which have affected solar and broader energy technology companies without any new company-specific announcements. At the same time, the company has remained a focus of investor attention with consistent earnings outperformance versus consensus, even as near-term earnings expectations and analyst sentiment have been mixed. We’ll now examine how this geopolitically driven...
NYSE:STUB
NYSE:STUBEntertainment

IPO Momentum Stocks One AI Spine Bet One Ticketing Sleeper

SpaceX’s blockbuster IPO, with its 19% first day jump to $160 and an estimated $1.77t valuation, has pulled fresh attention toward recently listed stocks that traders see as potential momentum plays. When a headline listing captures the market’s imagination, it can spill over into other young IPOs that already show strong price moves and active trading. This article looks at 3 stocks from the IPO Momentum Stocks screener that appear closely tied to this surge in enthusiasm around newly public...
NasdaqCM:APPS
NasdaqCM:APPSSoftware

Digital Turbine (APPS) Is Up 8.3% After Launching Its Unified Launchpad App Distribution Platform

Earlier this month, Digital Turbine launched Launchpad, a unified app distribution platform that ties together carrier and OEM integrations, SingleTap installs, direct app relationships, and a footprint of more than 82,000 apps across over 1.00 billion devices to power modern app discovery and installs. The platform is already being used by game developers such as Zynga, Playtika, King and mobile partners including Orange, Motorola, and Telefónica, highlighting how on-device distribution and...
NYSE:EMR
NYSE:EMRElectrical

High Quality Dividend Stocks One Cash Machine One Quiet Compounder

With inflation running at 4.2% on CPI, 6.5% on PPI and rate markets now pricing in a possible hike rather than cuts, income investors are suddenly playing a different game. Higher yields and a firm labor market can reward companies that already generate solid cash flow, carry manageable debt and keep dividends on a realistic footing. This article focuses on three stocks from a High Quality Dividend Stocks screener that fit that description and are directly exposed to the current interest rate...
NYSE:WRB
NYSE:WRBInsurance

W. R. Berkley (WRB) Stock Valuation Check After Mixed Recent Returns

Why W. R. Berkley (WRB) is Drawing Fresh Investor Attention W. R. Berkley (WRB) has been back on investors’ radar after recent trading left the stock with a mixed return profile, including a decline over the past year alongside solid multi year total returns. See our latest analysis for W. R. Berkley. Recent trading has been choppy, with a 1 day share price return of 1.08% and a 1 month share price return of 4.34%. The 1 year total shareholder return is down 4.36%, compared with much stronger...
NYSE:OGN
NYSE:OGNPharmaceuticals

Organon (OGN) Stock Valuation After FDA Expands TOFIDENCE Approval In US Biosimilars Market

Organon (OGN) is back in focus after the US Food and Drug Administration approved an expanded label for its tocilizumab biosimilar, TOFIDENCE, adding indications for severe cytokine release syndrome and certain hospitalized COVID-19 patients. See our latest analysis for Organon. At a latest share price of US$13.44, Organon’s 90 day share price return of 111.65% and year to date share price return of 85.64% contrast with a 3 year total shareholder return that declined 27.03%. This suggests...
NasdaqGS:AAPL
NasdaqGS:AAPLTech

Apple (AAPL) Stock After WWDC AI Disappointment A Fresh Look At Valuation And Overvaluation Risks

Apple (AAPL) is back in focus after its Worldwide Developers Conference, where the company revealed a revamped Siri AI and broader Apple Intelligence rollout, only to see the stock sell off on investor disappointment. See our latest analysis for Apple. The stock reaction around WWDC has been choppy, with a 1-day share price return of down 1.52% and a 7-day share price return of down 5.27% as investors reassessed the impact of Siri AI and Apple Intelligence. This is occurring even though the...
NYSE:M
NYSE:MMultiline Retail

Why Macy's (M) Is Up 14.5% After Q1 Beat, Guidance Hike And Analyst Upgrades – And What's Next

Macy’s, Inc. recently reported first-quarter 2026 results, with revenue of US$4,892 million and net income of US$63 million, and modestly raised its full-year net sales guidance to US$21.5 billion–US$21.75 billion, while also updating its ongoing share repurchase activity. Following these updates, several Wall Street firms upgraded their outlook on Macy’s turnaround efforts, highlighting improving operations even as some insiders sold shares and the company continues to face store closures...
NYSE:GPC
NYSE:GPCRetail Distributors

Genuine Parts (GPC) Is Up 5.7% After Elliott-Backed Split Plan - Has The Bull Case Changed?

Genuine Parts recently announced plans, following pressure from activist investor Elliott, to split by early 2027 into two independent publicly traded companies focused on Global Automotive and Global Industrial operations. The move aims to unlock value by giving each business a clearer identity and investor base, but raises questions around separation costs, potential dis-synergies, and how the future dividend policy will be structured across the two entities. We will now explore how the...
NYSE:DRD
NYSE:DRDMetals and Mining

DRDGOLD (NYSE:DRD) Stock Valuation Check After Recent Weak Momentum

Understanding DRDGOLD’s recent move DRDGOLD (DRD) recently drew attention after a one day gain of 2.27%, standing out against a period where the stock is down about 21% over the past month and 22% over the past 3 months. See our latest analysis for DRDGOLD. Despite the latest one day share price gain, DRDGOLD’s recent momentum has been fading, with the share price down over the past month and year to date, while the 1 year and multi year total shareholder returns remain strongly positive. If...
NYSE:F
NYSE:FAuto

Ford (F) Stock Valuation After Ford Energy Excitement And F-Series Production Recovery

Ford Motor (F) is back in focus after enthusiasm around its Ford Energy battery storage unit and the restart of a key aluminum supplier, developments that follow strong earnings and rising earnings estimates. See our latest analysis for Ford Motor. Ford’s recent momentum is clear, with a 30 day share price return of 9.36% and a 90 day share price return of 27.16%. The 1 year total shareholder return of 49.30% reflects how earnings, Ford Energy headlines, and improving aluminum supply are...
NYSE:CVLG
NYSE:CVLGTransportation

Covenant Logistics Group (CVLG) Stock Valuation Check After Strong Recent Price Momentum

Event context and recent stock move Covenant Logistics Group (CVLG) stock has drawn attention after a recent move that left shares at US$45.45, with the price higher over the past week, month and past 3 months. See our latest analysis for Covenant Logistics Group. The recent 1-day share price pullback of 1.88% comes after strong momentum, with a 30-day share price return of 42.25% and a 1-year total shareholder return of 101.74%. This indicates sentiment has strengthened over both short and...
NasdaqGS:LIVN
NasdaqGS:LIVNMedical Equipment

Is LivaNova’s (LIVN) Boardroom Refresh Quietly Reframing Its Long-Term Risk and Strategy Playbook?

LivaNova PLC recently elected experienced global executive Jette Nygaard-Andersen to its Board of Directors and appointed Anne Liddy as Chief Legal Officer, while long-serving director Dr. Sharon O’Kane stepped down after a decade on the Board. These governance changes bring fresh expertise in medtech, legal and compliance oversight, and executive leadership, potentially influencing how LivaNova manages regulatory complexity and long-term corporate priorities. We’ll now examine how adding...
NYSE:CNM
NYSE:CNMTrade Distributors

Core & Main (CNM) Stock Valuation After Earnings Beat Guidance Reaffirmation And Larger Buyback

Core & Main (CNM) is back in focus after first quarter results topped earnings expectations, municipal demand held up against weak residential construction, and management reaffirmed full year guidance while expanding its share repurchase authorization. See our latest analysis for Core & Main. The latest earnings beat and guidance reaffirmation come after a year where the share price has eased, with a year-to-date share price return of down 9.51%. The 3-year total shareholder return of 69.16%...
NYSE:SLGN
NYSE:SLGNPackaging

Silgan Holdings (SLGN) Rides Packaging Rally as Dividend Yield Draws Scrutiny of Its Risk-Reward Balance

In recent days, Silgan Holdings Inc. participated in a broad rally across the packaging sector, as investors showed increased interest in rigid packaging suppliers serving food, beverage, and household product markets. Amid this sector-wide momentum, Silgan’s above-average forward dividend yield and record of consistent dividend growth are drawing attention from income-focused and value-oriented investors weighing its risk profile. We’ll now explore how this sector-wide interest, alongside...
NasdaqGS:DNLI
NasdaqGS:DNLIBiotechs

Denali Therapeutics (DNLI) Stock Valuation After Setback In LUMA Trial And Focus On BEACON Study

Denali Therapeutics (DNLI) stock has been in focus after the company and Biogen halted the Phase 2b LUMA trial of BIIB122 for idiopathic Parkinson’s disease, following missed primary and secondary efficacy endpoints. For investors, attention now shifts to Denali’s planned independent Phase 2a BEACON trial in genetically targeted Parkinson’s patients. This keeps BIIB122 in the pipeline but with a narrower, more focused development path. See our latest analysis for Denali Therapeutics. At a...